Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

por Ullrich, T., Arsov, C., Quentin, M., Mones, F., Westphalen, A. C., Mally, D., Hiester, A., Albers, P., Antoch, G., Schimmöller, L.
Publicado 2020

Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins

por Quentin, M., Schimmöller, L., Ullrich, T., Valentin, B., Demetrescu, D., Al-Monajjed, R., Mally, D., Esposito, I., Albers, P., Antoch, G., Arsov, C.
Publicado 2022

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate

por Boschheidgen, M., Schimmöller, L., Doerfler, S., Al-Monajjed, R., Morawitz, J., Ziayee, F., Mally, D., Quentin, M., Arsov, C., Albers, P., Antoch, G., Ullrich, T.
Publicado 2022

MRI grading for the prediction of prostate cancer aggressiveness

por Boschheidgen, M., Schimmöller, L., Arsov, C., Ziayee, F., Morawitz, J., Valentin, B., Radke, K. L., Giessing, M., Esposito, I., Albers, P., Antoch, G., Ullrich, T.
Publicado 2021

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy

por Klingebiel, M, Arsov, C, Ullrich, T, Quentin, M, Al-Monajjed, R, Mally, D, Sawicki, LM, Hiester, A, Esposito, I, Albers, P, Antoch, G, Schimmöller, L
Publicado 2022

Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer

por Valentin, B., Schimmöller, L., Ullrich, T., Klingebiel, M., Demetrescu, D., Sawicki, L. M., Lakes, J., Mally, D., Quentin, M., Esposito, I., Albers, P., Antoch, G., Arsov, C.
Publicado 2021